Cue Biopharma (CUE) Earnings Analysis
Cue Biopharma (CUE) next reports earnings on 2026-08-18, consensus EPS -1.69 USD. Last quarter (2026-05-14) it beat with EPS -1.08 USD vs -3.3 USD est (+67.3%). It has beaten estimates in 5/6 recent quarters (83%). Trailing P/E -6.20.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CUE next report earnings?
| Next earnings date | 2026-08-18 |
|---|---|
| Consensus EPS estimate | -1.69 USD |
| Revenue estimate | 0.00B |
CUE earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | -1.08 USD | -3.3 USD | +67.3% | Beat |
| 2026-03-16 | 0.3 USD | -2.7 USD | +111.1% | Beat |
| 2025-05-12 | -0.17 USD | -0.14 USD | -21.4% | Miss |
| 2025-03-31 | -0.13 USD | -0.16 USD | +18.8% | Beat |
| 2024-11-14 | -0.17 USD | -0.2 USD | +15% | Beat |
| 2024-08-18 | -0.2 USD | -0.29 USD | +31% | Beat |
Beat rate: 5/6 (83%) over reported quarters with consensus data.
CUE valuation and analyst view
| Trailing P/E | -6.20 |
|---|---|
| Trailing EPS | -4.06095 USD |
| Price / book | 7.61 |
| Dividend yield | 0.00% |
| Market cap | 0.09B |
| Analyst consensus | Buy (9 buy / 0 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Cue Biopharma (CUE)'s next earnings date?
Cue Biopharma is next scheduled to report on 2026-08-18, with a consensus EPS estimate of -1.69 USD and revenue estimate of 0.00B.
Did CUE beat earnings last quarter?
In its 2026-05-14 report, CUE posted EPS of -1.08 USD versus a -3.3 USD estimate — a beat of 67.3%.
What is CUE's earnings track record?
Over the last 6 reported quarters with consensus data, CUE beat estimates 5 times (83%).
What is CUE's current P/E ratio and EPS?
CUE trades at a trailing P/E of -6.20 on trailing EPS of -4.060951506127725 USD.
What do analysts rate CUE?
Analyst consensus is "Buy" across 9 ratings (0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell).